Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
The rules say that a second diagnostic facet procedure is considered medically reasonable and necessary to 
confirm validity of the initial diagnostic facet procedure when administered at the same level. The second 
diagnostic procedure may only be performed a minimum of 2 weeks after the initial diagnostic procedure. 
1. An initial diagnostic facet joint procedure will be considered medically reasonable and 
necessary when the patient meets the criteria outlined under the indications for facet joint 
interventions. 
2. A second confirmatory diagnostic facet joint procedure is considered medically reasonable and 
necessary in patients who meet BOTH of the following criteria:  
 The patient meets the criteria for the first diagnostic procedure; AND 
 After the first diagnostic facet joint procedure, there must be a consistent positive 
response of at least 80% relief of primary (index) pain (with the duration of relief being 
consistent with the agent used). 
You can find this rule in Local Coverage Determination (LCD) Facet Joint Interventions for Pain Management 
L33930. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
The rules say that this diagnostic procedure which involves stimulation of peripheral nerves by a needle 
electrode inserted through the skin is performed only in a physician's office, clinic, or hospital outpatient 
department. Therefore, it is covered only when performed by a physician or incident to physician's service. If 
pain is effectively controlled by percutaneous stimulation, implantation of electrodes is warranted. 
As in the case of TENS (described in subsection A), generally the physician should be able to determine 
whether the patient is likely to derive a significant therapeutic benefit from continuing use of an implanted 
nerve stimulator within a trial period of 1 month. In a few cases, this determination may take longer to make. 
The medical necessity for such diagnostic services which are furnished beyond the first month must be 
documented. You can find this information in National Coverage Determination (NCD) Assessing Patient's 
Suitability for Electrical Nerve Stimulation Therapy 160.7.1. 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit includes an 
annual dental maximum of $500. You can find this information on pages 4-59 to 4-64 of the Plan's 2022 
Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will cover unilateral or bilateral thalamic ventralis intermedius nucleus (VIM) deep 
brain stimulation (DBS) for the treatment of essential tremor (ET) and/or Parkinsonian tremor and unilateral or 
bilateral subthalamic nucleus (STN) or globus pallidus interna (GPi) DBS for the treatment of Parkinson's 
disease (PD) only under the following conditions: 
1. Medicare will only consider DBS devices to be reasonable and necessary if they are Food and Drug 
Administration (FDA) approved devices for DBS or devices used in accordance with FDA approved 
protocols governing Category B Investigational Device Exemption (IDE) DBS clinical trials. 
2. For thalamic VIM DBS to be considered reasonable and necessary, patients must meet all of the 
following criteria: 
a. Diagnosis of ET based on postural or kinetic tremors of hand(s) without other neurologic signs, 
or diagnosis of idiopathic PD (presence of at least 2 cardinal PD features (tremor, rigidity or 
bradykinesia)) which is of a tremor-dominant form. 
b. Marked disabling tremor of at least level 3 or 4 on the Fahn-Tolosa-Marin Clinical Tremor 
Rating Scale (or equivalent scale) in the extremity intended for treatment, causing significant 
limitation in daily activities despite optimal medical therapy. 
c. Willingness and ability to cooperate during conscious operative procedure, as well as during 
post-surgical evaluations, adjustments of medications and stimulator settings. 
3. For STN or GPi DBS to be considered reasonable and necessary, patients must meet all of the following 
criteria: 
a. Diagnosis of PD based on the presence of at least 2 cardinal PD features (tremor, rigidity or 
bradykinesia). 
b. Advanced idiopathic PD as determined by the use of Hoehn and Yahr stage or Unified 
Parkinson's Disease Rating Scale (UPDRS) part III motor subscale. 
c. L-dopa responsive with clearly defined "on" periods. 
d. Persistent disabling Parkinson's symptoms or drug side effects (e.g., dyskinesias, motor 
fluctuations, or disabling "off" periods) despite optimal medical therapy. 
e. Willingness and ability to cooperate during conscious operative procedure, as well as during 
post-surgical evaluations, adjustments of medications and stimulator settings. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 
100-03, Medicare National Coverage Determination for Deep Brain Stimulation for Essential Tremor and 
Parkinsons Disease, 160.24.  
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that the accepted treatments for eliminating saphenous (great saphenous vein (GSV), anterior 
accessory GSV (AAGSV), small saphenous vein (SSV)) reflux (saphenofemoral or saphenopopliteal) are 
radiofrequency ablation (RFA), laser ablation (EVLA), polidocanol microfoam (PEM), cyanoacrylate 
embolization (CAE) ablation, and mechanochemical ablation (MOCA).  
 
RFA and EVLA are classified as thermal tumescent (TT) techniques; PEM, CAE and MOCA are non-thermal 
non-tumescent (NTNT) techniques. Each endovenous ablation approach has advantages and disadvantages; 
which one is best depends on the unique clinical/anatomical scenario. While saphenous vein ligation and 
stripping remains an important option in selected cases, it has been largely supplanted by endovenous ablation 
therapy as primary treatment of saphenous (axial/truncal) vein incompetence. The treatments to eliminate the 
saphenous vein reflux will be considered medically necessary if the patient remains symptomatic after a six-
week trial of conservative therapy and has reflux in a saphenous vein. 
 
The treatments for symptomatic varicose tributaries are either compressive sclerotherapy or microphlebectomy. 
The treatments of the tributary veins will be considered medically necessary if saphenous reflux is not present 
or already successfully eliminated, the veins are greater than 4 mm in diameter and if the patient remains 
symptomatic after a six-week trial of conservative therapy.   
 
The patient is considered symptomatic if any of the following signs and symptoms of significantly diseased 
vessels of the lower extremities are documented in the medical record: 
 stasis ulcer of the lower leg, 
 significant pain and significant edema that interferes with activities of daily living, 
 bleeding associated with the diseased vessels of the lower extremities, 
 recurrent episodes of superficial phlebitis, 
 stasis dermatitis, or 
 refractory dependent edema. 
 
You can find this rule in the Local Coverage Determination for Treatment of Varicose Veins of the Lower 
Extremity, L33575.  If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
  Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 90-91 of the Plan's 2023 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
 
The rules say that the following two germline hereditary mutation tests will be considered medically reasonable 
and necessary when performed for evaluation of venous thromboembolism. Refer to ICD-10 Code Group 3 in 
the related Local Coverage Article: Billing and Coding: Biomarkers Overview A56541. 
 Factor II (F2 gene) 
 Factor V (F5 gene) 
You can find this information in Local Coverage Determination (LCD) Biomarkers Overview L35062. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that are not medically necessary are not covered. The rules also say that 
experimental and investigational devices are not covered. You can find this rule at 42 CFR Sections 411.15 and 
411.15(o). 
 
The rules say that Medicare coverage for cataract extraction and cataract extraction with intraocular lens 
implant is based on services that are reasonable and medically necessary for the treatment of beneficiaries with 
cataract(s). This local coverage determination (LCD)defines coverage and describes criteria necessary to justify 
the performance of cataract extraction(s) or other select lensectomies. You can find the rules in Local Coverage 
Determination (LCD) Cataract Extraction L33558. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay 20% coinsurance for Medicare Part B drugs. You can find this 
information on page(s) 4-28 of the Plan's 2022 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that for home health agencies may not submit this claim until after all services are provided for 
the period and the physician has signed the plan of care and any subsequent verbal order. You can find this 
information in the Centers for Medicare and Medicaid Services, Internet-Only Manual, Publication 100-04, 
Medicare Claims Processing Manual, Chapter 10, Section 10.1.10.4. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that the following data elements are required to submit a claim under home health PPS. For 
billing of home health claims not under an HH plan of care (not under HH PPS), see 90. Home health services 
under a plan of care are paid based on a 30-day period of care. HHAs submit an NOA at the beginning of an 
admission and then submit one claim for each 30-day period of care. Claims submitted before an NOA has 
been received for the beneficiary will be returned to the provider. 
 
HHAs report the Core Based Statistical Area (CBSA) number (or rural state code) of the location where the 
home health or hospice service is delivered. The HHA reports the number in dollar portion of the form locator 
right justified to the left of the dollar/cents delimiter, add two zeros to the cents field if no cents. 
 
Where required by law or regulation, report the Federal Information Processing Standards (FIPS) State and 
County Code of the place of residence where the home health service is delivered. 
 
You can find this information in the Centers for Medicare and Medicaid Services, Internet-Only Manual, 
Publication 100-04, Medicare Claims Processing Manual, Chapter 10, Section 10.1.10.3. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Facet Joint Interventions are considered medically reasonable and necessary for the diagnosis 
and treatment of chronic pain in patients who meet ALL of the following criteria: 
 
  
  1. Moderate to severe chronic neck or low back pain, predominantly axial, that causes functional deficit 
measured on pain or disability scale; AND 
2. Pain that has been present for a minimum of 3 months with documented failure to respond to 
noninvasive conservative care management (as tolerated); AND 
3. Absence of untreated radiculopathy or neurogenic claudication (except for radiculopathy caused by 
facet joint synovial cyst); AND 
4. There is no non-facet pathology per clinical assessment or radiology studies that could explain the 
source of the patients pain, including but not limited to fracture, tumor, infection, or significant deformity. 
 
The primary indication of a diagnostic facet joint procedure is to diagnose whether the patient has facet 
syndrome. You can find this information in the Local Coverage Determination (LCD): Facet Joint 
Interventions for Pain Management (L34892). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that plans may choose the networks of providers available to enrollees and may require enrollees 
to obtain authorization before receiving services. You can find this rule at 42 CFR Section 422.112(a) and in 
the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-16, Medicare 
Managed Care Manual, Chapter 1, Section 20.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information on page(s) 7 to 8 of the Plan's 
2022 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that infliximab is considered medically necessary for specific circumstances only. You can find 
this rule at Local Coverage Determination (LCD) L35677: Infliximab (eff. 8/5/21). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.